Pure Bioscience's market cap is currently $7.49M. The company's EPS TTM is $-0.029; its P/E ratio is ―; Pure Bioscience is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 1.96M	$ 1.88M	$ 1.85M	$ 3.93M	$ 6.92M
Gross Profit	$ 1.15M	$ 971.00K	$ 1.00M	$ 2.08M	$ 4.02M
Operating Income	$ -3.13M	$ -3.94M	$ -3.42M	$ -2.31M	$ 9.00K
EBITDA	$ -3.05M	$ -3.83M	$ -3.27M	$ -2.14M	$ 201.00K
Net Income	$ -3.35M	$ -3.96M	$ -3.50M	$ -2.32M	$ -6.00K
Balance Sheet
Cash & Short-Term Investments	$ 424.00K	$ 1.09M	$ 3.39M	$ 2.39M	$ 3.84M
Total Assets	$ 818.00K	$ 1.82M	$ 4.48M	$ 4.30M	$ 6.32M
Total Debt	$ 2.95M	$ 1.02M	$ 0.00	$ 239.00K	$ 0.00
Net Debt	$ 2.60M	$ -74.00K	$ -3.39M	$ -2.15M	$ -3.84M
Total Liabilities	$ 3.68M	$ 1.55M	$ 575.00K	$ 970.00K	$ 1.51M
Stockholders' Equity	$ -2.86M	$ 272.00K	$ 3.91M	$ 3.33M	$ 4.81M
Cash Flow
Free Cash Flow	$ -2.53M	$ -3.31M	$ -2.50M	$ -1.69M	$ 611.00K
Operating Cash Flow	$ -2.53M	$ -3.28M	$ -2.42M	$ -1.17M	$ 669.00K
Investing Cash Flow	$ 0.00	$ -33.00K	$ -81.00K	$ -521.00K	$ -58.00K
Financing Cash Flow	$ 1.78M	$ 1.01M	$ 3.50M	$ 239.00K	$ 2.83M

Currency in USD

Pure Bioscience Earnings and Revenue History

Income Statement >

Pure Bioscience Debt to Assets

Balance Sheet >

Pure Bioscience Cash Flow

Cash Flow >

Pure Bioscience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing